InsidersTradesSigma
Follow the 에이비엘바이오 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 에이비엘바이오 has logged 69 insider filings. Market capitalisation: €3,963.9bn. The latest transaction was filed on 6 July 2026 (Other). Among the most active insiders: LEESANGHOON. The full history is free.
69
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
n/a
38 ops.
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,638 of 29,052 companies
35.0
score / 100
Value31
Quality40
FCF yld-1.6%
Earn yld-0.9%
EV/EBITDA·
ROE-15%
Gross mgn100%
Net mgn-48%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 6 July 2026
Declarations69 total
0KRXDART:20260403003473
687,000 sharesKRXDART:20251205000487
173,533 sharesKRXDART:20250404004101
35,000 sharesShareKRXDART:20250207000891
10,679 sharesKRXDART:20250103000564
21,000 sharesKRXDART:20241008000559
2,316,762 sharesKRXDART:20240905000405
8,000 sharesKRXDART:20240830002194
4,408,440 sharesKRXDART:20240719000482
0KRXDART:20240705000157
8,000 sharesKRXDART:20240701000228
382,737 sharesKRXDART:20240405003343
9,633 sharesKRXDART:20240405003288
8,000 sharesKRXDART:20231006000533
25 of 69 declarations
About 에이비엘바이오
Listed on the XKRX market, ABLE Bio specializes in the healthcare and pharmaceutical sector. The company focuses on developing innovative treatments for various diseases.